z-logo
open-access-imgOpen Access
P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME
Author(s) -
Palandri F.,
Bartoletti D.,
Breccia M.,
Auteri G.,
Elli E. M.,
Trawinska M. M.,
Polverelli N.,
Tiribelli M.,
Benevolo G.,
Iurlo A.,
Tieghi A.,
Heidel F. H.,
Caocci G.,
Beggiato E.,
Binotto G.,
Cavazzini F.,
Miglino M.,
Bosi C.,
Crugnola M.,
Bocchia M.,
Martino B.,
Pugliese N.,
Romagnoli A. D.,
Mazzoni C.,
Scaffidi L.,
Isidori A.,
Cattaneo D.,
Krampera M.,
Pane F.,
Cilloni D.,
Semenzato G.,
Lemoli R. M.,
Cuneo A.,
Abruzzese E.,
Vianelli N.,
Cavo M.,
Bonifacio M.,
Palumbo G. A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846908.10695.dd
Subject(s) - ruxolitinib , myelofibrosis , medicine , leukopenia , essential thrombocythemia , myeloproliferative neoplasm , polycythemia vera , anemia , international prognostic scoring system , hematology , population , oncology , gastroenterology , bone marrow , toxicity , myelodysplastic syndromes , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here